Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Valentina Grossi, Francesca Gulli, Maria Infantino, Annunziata Stefanile, Cecilia Napodano, Maurizio Benucci, Krizia Pocino, Francesca Li Gobbi, Arianna Damiani, Antonella Di Pino, Mariangela Manfredi, Mariapaola Marino, Valerio Basile, Gian Ludovico Rapaccini & Umberto Basile. (2020) The Laboratory Role in anti-TNF Biological Therapy Era. Immunological Investigations 49:3, pages 317-332.
Read now
Read now
Itishree Trivedi & Stephen B Hanauer. (2015) Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases. Expert Opinion on Drug Safety 14:12, pages 1915-1934.
Read now
Read now
Articles from other publishers (17)
Vishal Pavitrakar, Rustom ModySelvan Ravindran. (2022) Amelioration of Cisplatin-induced Renal Inflammation by Recombinant Human Golimumab in Mice. Current Pharmaceutical Biotechnology 23:7, pages 970-977.
Crossref
Crossref
Ashvini Reddy, Fauziyya Muhammad & Darren J. Lee. 2019. Advances in the Diagnosis and Management of Uveitis. Advances in the Diagnosis and Management of Uveitis.
Laure Benoit, Olivier Mir & Paul Berveiller. (2019) Treating Ulcerative Colitis During Pregnancy: Evidence of Materno–Fetal Transfer of Golimumab. Journal of Crohn's and Colitis 13:5, pages 669-670.
Crossref
Crossref
Pablo Olivera, Silvio Danese, Lieven Pouillon, Stefanos Bonovas & Laurent Peyrin-Biroulet. (2019) Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence. Digestive and Liver Disease 51:3, pages 327-334.
Crossref
Crossref
Brian Bressler, Martin Williamson, Bernie Sattin, Fernando Camacho & A Hillary Steinhart. (2018) Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure. Journal of the Canadian Association of Gastroenterology 1:3, pages 129-134.
Crossref
Crossref
Beatrice Orlandini, Gabriele Dragoni, Angela Variola, Arianna Massella, Siro Bagnoli, Riccardo Campi & Francesca Rogai. (2018) Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real-life experience from two Italian IBD centers. Journal of Digestive Diseases 19:8, pages 468-474.
Crossref
Crossref
Benjamin Wakefield & Cath Stansfield. (2018) Prescribing options for ulcerative colitis. Nurse Prescribing 16:Sup7, pages 9-13.
Crossref
Crossref
Benjamin Wakefield & Cath Stansfield. (2018) Biologic therapies in ulcerative colitis. Gastrointestinal Nursing 16:3, pages 24-26.
Crossref
Crossref
Toshifumi Hibi, Yuya Imai, Asako Senoo, Kentaro Ohta & Yoshifumi Ukyo. (2017) Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study). Journal of Gastroenterology 52:10, pages 1101-1111.
Crossref
Crossref
Grainne Holleran, Loris Lopetuso, Valentina Petito, Cristina Graziani, Gianluca Ianiro, Deirdre McNamara, Antonio Gasbarrini & Franco Scaldaferri. (2017) The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. International Journal of Molecular Sciences 18:10, pages 2020.
Crossref
Crossref
Duk Hwan KimJae Hee Cheon. (2017) Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Network 17:1, pages 25.
Crossref
Crossref
Ines Harzallah, Josselin Rigaill, Nicolas Williet, Stephane Paul & Xavier Roblin. (2016) Golimumab pharmacokinetics in ulcerative colitis: a literature review. Therapeutic Advances in Gastroenterology 10:1, pages 89-100.
Crossref
Crossref
Mark A. Samaan & Peter M. Irving. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
441
448
.
Iris Detrez, Erwin Dreesen, Thomas Van Stappen, Annick de Vries, Els Brouwers, Gert Van Assche, Séverine Vermeire, Marc Ferrante & Ann Gils. (2016) Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis. Journal of Crohn's and Colitis 10:5, pages 575-581.
Crossref
Crossref
Zacharias Fasoulakis, Panagiotis Antsaklis, Nikolaos Galanopoulos & Emmanuel Kontomanolis. (2016) Common Adverse Effects of Anti-TNF Agents on Gestation. Obstetrics and Gynecology International 2016, pages 1-6.
Crossref
Crossref
Shusheng Geng, Hong Chang, Weisong Qin, Ming Lv, Yan Li, Jiannan Feng & Beifen Shen. (2015) A novel anti-TNF scFv constructed with human antibody frameworks and antagonistic peptides. Immunologic Research 62:3, pages 377-385.
Crossref
Crossref
Mark Löwenberg & Geert D’Haens. (2015) Next-Generation Therapeutics for IBD. Current Gastroenterology Reports 17:6.
Crossref
Crossref